Barriers to medication entitlements after diagnosis of ADHD Reply
Kapil Sayal, Vibhore Prasad, David Daley, Tamsin Ford, David Coghill
The Lancet Psychiatry | ELSEVIER SCI LTD | Published : 2018
DD reports grants, personal fees, and non-financial support from Shire, personal fees and non-financial support from Eli Lilly and Medice, and book royalties from Jessica Kingsley, outside the submitted work. DC reports grants and personal fees from Shire, personal fees from Eli Lilly and Novartis, grants from Vifor, and book royalties from Oxford University Press, outside the submitted work. KS is a member of the National Institute for Health and Clinical Excellence Guideline Development Group for ADHD. VP is funded by the National Institute for Health Research Academic Clinical Lecturer scheme. All other authors declare no competing interests.